SCHEMBL18673586

SCHEMBL18673586

COC(=O)c1nn(-c2cccc(C)c2)c2nnccc12

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 1/20 0.56
▸ ELANE P08246 5/20 0.46
▸ F2 P00734 3/20 0.46
▸ PLAU P00749 3/20 0.46
▸ MAP3K14 Q99558 1/20 0.43
▸ MEN1 O00255 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ RXFP1 Q9HBX9 1/20 0.42
▸ ALDH1A1 P00352 3/20 0.42
▸ CTRB1 P17538 2/20 0.41
▸ LMNA P02545 3/20 0.40
▸ MAPT P10636 3/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ CYP1A2 P05177 2/20 0.40
▸ CYP2C9 P11712 2/20 0.40
▸ CYP2C19 P33261 2/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ ALOX15 P16050 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16532655 0.88 MAP3K14 (0.43) GAAELANEF2PLAUMAP3K14
SCHEMBL18673460 0.81 GAA (0.52) GAAELANEF2PLAUMAP3K14
SCHEMBL18673582 0.79 GAA (0.53) GAAELANEF2PLAUMAP3K14
SCHEMBL18673502 0.78 ELANE (0.65) GAAELANEF2PLAUKMT2A
SCHEMBL18673413 0.74 GAA (0.53) GAAELANEF2PLAUMAP3K14
SCHEMBL18673430 0.74 MAP3K14 (0.51) GAAELANEF2PLAUMAP3K14
SCHEMBL16532657 0.74 MAP3K14 (0.82) MAP3K14
SCHEMBL16516723 0.73 MAP3K14 (0.43) MAP3K14ALDH1A1MAPTKDM4EPKM
SCHEMBL10258552 0.72 CYP1A2 (0.61) GAAMEN1KMT2ARXFP1ALDH1A1
SCHEMBL16532313 0.72 PDE4A (0.48) GAAELANEF2PLAUMAP3K14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170145034-A1 ALKYNYL ALCOHOLS AND METHODS OF USE GENENTECH, INC. (US) 2017-05-25 — — US disclosed
US-9605005-B2 Alkynyl alcohols and methods of use GENENTECH, INC. (US) 2017-03-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170145034-A1 ALKYNYL ALCOHOLS AND METHODS OF USE NFKB2, NFKB1, RELA GAA 1695/4885ELANE 1188/4885F2 1432/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback